Statements of Cash Flows - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash flows from Operating Activities
Net income/(loss)	$ (1,497)	$ 3,813,684
Adjustments to reconcile net income to net cash used in operating activities:
Unrealized gain on investments held in Trust Account		(4,087)
Financing costs - derivative warrant liabilities		479,936
Change in fair value of derivative warrants liabilities		(4,725,000)
Changes in operating assets and liabilities:
Prepaid expenses		(522,874)
Accounts payable		135,005
Accrued expenses	1,497
Franchise tax payable		123,338
Net cash used in operating activities		(699,998)
Cash Flows from Investing Activities:
Cash deposited in Trust Account		(210,105,000)
Net cash used in investing activities		(210,105,000)
Cash flows from Financing Activities
Proceeds from note payable to related party		197,000
Repayment of note payable to related party		(197,000)
Proceeds received from initial public offering		207,000,000
Proceeds received from private placement		8,100,000
Payment of offering costs	(12,500)	(3,270,809)
Proceeds from sale of shares of common stock to initial stockholder	25,000
Net cash provided by financing activities	12,500	211,829,191
Net change in cash	12,500	1,024,193
Cash at beginning of period		12,500
Cash at end of period	12,500	1,036,693
Offering costs included in accrued expenses	96,753
Deferred underwriting fee payable		$ 7,245,000